D printed hydrogel expanders use controlled buckling and low pressure to generate new soft tissue while preserving viability ...
Following the first Phase 3 study of HyBryte(TM) for the treatment of CTCL, the FDA and the EMA indicated that they would require a second successful Phase 3 trial to support mark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback